{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T22:06:23Z","timestamp":1781129183111,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"DOI":"10.1007\/s00223-023-01094-z","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T19:03:22Z","timestamp":1684868602000},"page":"166-174","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Bone Mineral Density in Neurofibromatosis Type 1: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6501-6180","authenticated-orcid":false,"given":"Nipith","family":"Charoenngam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuuwadith","family":"Wattanachayakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aunchalee","family":"Jaroenlapnopparat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patompong","family":"Ungprasert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jirat","family":"Chenbhanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,23]]},"reference":[{"issue":"2","key":"1094_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ajmg.a.33139","volume":"152A","author":"DG Evans","year":"2010","unstructured":"Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM, Lalloo F (2010) Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A 152A(2):327\u2013332. https:\/\/doi.org\/10.1002\/ajmg.a.33139","journal-title":"Am J Med Genet A"},{"issue":"1","key":"1094_CR2","doi-asserted-by":"publisher","first-page":"17004","DOI":"10.1038\/nrdp.2017.4","volume":"3","author":"DH Gutmann","year":"2017","unstructured":"Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ (2017) Neurofibromatosis type 1. Nat Rev Dis Primers 3(1):17004. https:\/\/doi.org\/10.1038\/nrdp.2017.4","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"1094_CR3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.spen.2006.01.005","volume":"13","author":"JH Tonsgard","year":"2006","unstructured":"Tonsgard JH (2006) Clinical manifestations and management of neurofibromatosis type 1. Semin Pediatr Neurol 13(1):2\u20137. https:\/\/doi.org\/10.1016\/j.spen.2006.01.005","journal-title":"Semin Pediatr Neurol"},{"issue":"5","key":"1094_CR4","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1399-0004.2005.00410.x","volume":"67","author":"S Alwan","year":"2005","unstructured":"Alwan S, Tredwell SJ, Friedman JM (2005) Is osseous dysplasia a primary feature of neurofibromatosis 1 (NF1)? Clin Genet 67(5):378\u2013390. https:\/\/doi.org\/10.1111\/j.1399-0004.2005.00410.x","journal-title":"Clin Genet"},{"issue":"7","key":"1094_CR5","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1002\/ajmg.a.36001","volume":"161","author":"L Armstrong","year":"2013","unstructured":"Armstrong L, Jett K, Birch P, Kendler DL, McKay H, Tsang E, Stevenson DA, Hanley DA, Egeli D, Burrows M, Friedman JM (2013) The generalized bone phenotype in children with neurofibromatosis 1: a sibling matched case-control study. Am J Med Genet A 161(7):1654\u20131661. https:\/\/doi.org\/10.1002\/ajmg.a.36001","journal-title":"Am J Med Genet A"},{"issue":"1","key":"1094_CR6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ymgme.2007.12.004","volume":"94","author":"N Brunetti-Pierri","year":"2008","unstructured":"Brunetti-Pierri N, Doty SB, Hicks J, Phan K, Mendoza-Londono R, Blazo M, Tran A, Carter S, Lewis RA, Plon SE, Phillips WA, O\u2019Brian Smith E, Ellis KJ, Lee B (2008) Generalized metabolic bone disease in neurofibromatosis type I. Mol Genet Metab 94(1):105\u2013111. https:\/\/doi.org\/10.1016\/j.ymgme.2007.12.004","journal-title":"Mol Genet Metab"},{"issue":"1","key":"1094_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jocd.2009.10.002","volume":"13","author":"C Caffarelli","year":"2010","unstructured":"Caffarelli C, Gonnelli S, Tanzilli L, Vivarelli R, Tamburello S, Balestri P, Nuti R (2010) Quantitative ultrasound and dual-energy X-ray absorptiometry in children and adolescents with neurofibromatosis of type 1. J Clin Densitom 13(1):77\u201383. https:\/\/doi.org\/10.1016\/j.jocd.2009.10.002","journal-title":"J Clin Densitom"},{"issue":"5","key":"1094_CR8","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1590\/1806-9282.66.5.666","volume":"66","author":"MLR De Souza","year":"2020","unstructured":"De Souza MLR, Jansen AK, Rodrigues LOC, Vilela DLDS, Kakehasi AM, Martins AS, De Souza JF, De Rezende NA (2020) Reduced bone mineral content and density in neurofibromatosis type 1 and its association with nutrient intake. Rev Assoc Med Bras 66(5):666\u2013672. https:\/\/doi.org\/10.1590\/1806-9282.66.5.666","journal-title":"Rev Assoc Med Bras"},{"issue":"4","key":"1094_CR9","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/01.bpb.0000271310.87997.ae","volume":"27","author":"S Dulai","year":"2007","unstructured":"Dulai S, Briody J, Schindeler A, North KN, Cowell CT, Little DG (2007) Decreased bone mineral density in neurofibromatosis type 1: results from a pediatric cohort. J Pediatr Orthopaed 27(4):472\u2013475. https:\/\/doi.org\/10.1097\/01.bpb.0000271310.87997.ae","journal-title":"J Pediatr Orthopaed"},{"key":"1094_CR10","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.1016\/j.bone.2009.04.072","volume":"45","author":"JA Eelloo","year":"2009","unstructured":"Eelloo JA, Huson SM, Ward KA, Adams JE, Russell SA, Wright NB, Evans DGR, Mughal MZ (2009) Reduced spinal bone mineral density (BMD) in pre-pubertal children with neurofibromatosis type 1 (NF1). Bone 45:S68\u2013S69. https:\/\/doi.org\/10.1016\/j.bone.2009.04.072","journal-title":"Bone"},{"issue":"2","key":"1094_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00223-018-0488-z","volume":"104","author":"M Filopanti","year":"2019","unstructured":"Filopanti M, Verga U, Ulivieri FM, Giavoli C, Rodari G, Arosio M, Natacci F, Spada A (2019) Trabecular bone score (TBS) and bone metabolism in patients affected with type 1 neurofibromatosis (NF1). Calcif Tissue Int 104(2):207\u2013213. https:\/\/doi.org\/10.1007\/s00223-018-0488-z","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"1094_CR12","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.pepo.2017.07.006","volume":"92","author":"A Hagner","year":"2017","unstructured":"Hagner A, Marja\u0144ska A, Dziedzic M, Jatczak-Gaca A, Styczy\u0144ski J, Roma\u0144czuk B, Odrow\u0105\u017c-Sypniewska G, Wysocki M (2017) Evaluation of bone abnormalities in children with neurofibromatosis type 1. Pediatr Pol 92(6):675\u2013680. https:\/\/doi.org\/10.1016\/j.pepo.2017.07.006","journal-title":"Pediatr Pol"},{"issue":"11","key":"1094_CR13","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1002\/jbmr.1685","volume":"27","author":"E Heerv\u00e4","year":"2012","unstructured":"Heerv\u00e4 E, Koffert A, Jokinen E, Kuorilehto T, Peltonen S, Aro HT, Peltonen J (2012) A controlled register-based study of 460 neurofibromatosis 1 patients: increased fracture risk in children and adults over 41 years of age. J Bone Miner Res 27(11):2333\u20132337. https:\/\/doi.org\/10.1002\/jbmr.1685","journal-title":"J Bone Miner Res"},{"issue":"10","key":"1094_CR14","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s001980170032","volume":"12","author":"T Ill\u00e9s","year":"2001","unstructured":"Ill\u00e9s T, Halmai V, De Jonge T, Dubousset J (2001) Decreased bone mineral density in neurofibromatosis-1 patients with spinal deformities. Osteoporos Int 12(10):823\u2013827. https:\/\/doi.org\/10.1007\/s001980170032","journal-title":"Osteoporos Int"},{"issue":"3","key":"1094_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.5114\/polp.2019.86435","volume":"94","author":"E Jakubowska-Pietkiewicz","year":"2019","unstructured":"Jakubowska-Pietkiewicz E, Wo\u017aniak E, Chlebna-Sok\u00f3\u0142 D, Micha\u0142us I (2019) Skeletal complications in the course of neurofibromatosis in children. Pediatr Pol 94(3):151\u2013157. https:\/\/doi.org\/10.5114\/polp.2019.86435","journal-title":"Pediatr Pol"},{"issue":"6","key":"1094_CR16","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1007\/s00223-021-00807-6","volume":"108","author":"M Jalabert","year":"2021","unstructured":"Jalabert M, Ferkal S, Souberbielle JC, Sbidian E, Mageau A, Eymard F, Le Corvoisier P, Allanore L, Chevalier X, Wolkenstein P, Guignard S (2021) Bone status according to neurofibromatosis type 1 phenotype: a descriptive study of 60 women in France. Calcif Tissue Int 108(6):738\u2013745. https:\/\/doi.org\/10.1007\/s00223-021-00807-6","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"1094_CR17","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1530\/ERC-12-0293","volume":"19","author":"MB Lodish","year":"2012","unstructured":"Lodish MB, Dagalakis U, Sinaii N, Bornstein E, Kim A, Lokie KB, Baldwin AM, Reynolds JC, Dombi E, Stratakis CA, Widemann BC (2012) Bone mineral density in children and young adults with neurofibromatosis type 1. Endocr Relat Cancer 19(6):817\u2013825. https:\/\/doi.org\/10.1530\/ERC-12-0293","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"1094_CR18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00403-011-1191-3","volume":"304","author":"L Petramala","year":"2012","unstructured":"Petramala L, Giustini S, Zinnamosca L, Marinelli C, Colangelo L, Cilenti G, Formicuccia MC, D\u2019Erasmo E, Calvieri S, Letizia C (2012) Bone mineral metabolism in patients with neurofibromatosis type 1 (von Recklingausen disease). Arch Dermatol Res 304(4):325\u2013331","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"1094_CR19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1515\/jpem-2016-0092","volume":"30","author":"HG Poyrazo\u01e7lu","year":"2017","unstructured":"Poyrazo\u01e7lu HG, Ba\u015f VN, Arslan A, Bastug F, Canpolat M, Per H, G\u00fcm\u00fcs H, Kumandas S (2017) Bone mineral density and bone metabolic markers\u2019 status in children with neurofibromatosis type 1. J Pediatr Endocrinol Metab 30(2):175\u2013180. https:\/\/doi.org\/10.1515\/jpem-2016-0092","journal-title":"J Pediatr Endocrinol Metab"},{"key":"1094_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-018-0507-8","author":"G Rodari","year":"2018","unstructured":"Rodari G, Scuvera G, Ulivieri FM, Profka E, Menni F, Saletti V, Esposito S, Bergamaschi S, Ferrante E, Eller-Vainicher C, Esposito S, Arosio M, Giavoli C (2018) Progressive bone impairment with age and pubertal development in neurofibromatosis type I. Arch Osteoporos. https:\/\/doi.org\/10.1007\/s11657-018-0507-8","journal-title":"Arch Osteoporos"},{"issue":"1","key":"1094_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00198-009-0933-y","volume":"21","author":"S Seitz","year":"2010","unstructured":"Seitz S, Schnabel C, Busse B, Schmidt HU, Beil FT, Friedrich RE, Schinke T, Mautner VF, Amling M (2010) High bone turnover and accumulation of osteoid in patients with neurofibromatosis 1. Osteoporos Int 21(1):119\u2013127. https:\/\/doi.org\/10.1007\/s00198-009-0933-y","journal-title":"Osteoporos Int"},{"key":"1094_CR22","doi-asserted-by":"publisher","first-page":"S139","DOI":"10.1002\/jbmr.5650251303","volume":"25","author":"P Simm","year":"2010","unstructured":"Simm P, Briody J, Schindeler A, Cowell C, Little D, North K, Munns C (2010) Bone health in children with neurofibromatosis type 1-a high incidence of abnormal vertebral morphology and altered skeletal geometry. J Bone Miner Res 25:S139\u2013S140. https:\/\/doi.org\/10.1002\/jbmr.5650251303","journal-title":"J Bone Miner Res"},{"issue":"8","key":"1094_CR23","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1111\/j.1651-2227.2007.00401.x","volume":"96","author":"K Yilmaz","year":"2007","unstructured":"Yilmaz K, Ozmen M, Bora Goksan S, Eskiyurt N (2007) Bone mineral density in children with neurofibromatosis 1. Acta Paediatrica Int J Paediatr 96(8):1220\u20131222. https:\/\/doi.org\/10.1111\/j.1651-2227.2007.00401.x","journal-title":"Acta Paediatrica Int J Paediatr"},{"issue":"20","key":"1094_CR24","doi-asserted-by":"publisher","first-page":"3910","DOI":"10.1093\/hmg\/ddr310","volume":"20","author":"W Wang","year":"2011","unstructured":"Wang W, Nyman JS, Ono K, Stevenson DA, Yang X, Elefteriou F (2011) Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type I. Hum Mol Genet 20(20):3910\u20133924. https:\/\/doi.org\/10.1093\/hmg\/ddr310","journal-title":"Hum Mol Genet"},{"issue":"7","key":"1094_CR25","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/gim.2018.28","volume":"20","author":"DR Stewart","year":"2018","unstructured":"Stewart DR, Korf BR, Nathanson KL, Stevenson DA, Yohay K (2018) Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med 20(7):671\u2013682. https:\/\/doi.org\/10.1038\/gim.2018.28","journal-title":"Genet Med"},{"issue":"3","key":"1094_CR26","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/jrsm.1296","volume":"9","author":"T Mathes","year":"2018","unstructured":"Mathes T, Kuss O (2018) A comparison of methods for meta-analysis of a small number of studies with binary outcomes. Res Synth Methods 9(3):366\u2013381. https:\/\/doi.org\/10.1002\/jrsm.1296","journal-title":"Res Synth Methods"},{"issue":"23","key":"1094_CR27","doi-asserted-by":"publisher","first-page":"4818","DOI":"10.1093\/hmg\/ddt333","volume":"22","author":"R Sharma","year":"2013","unstructured":"Sharma R, Wu X, Rhodes SD, Chen S, He Y, Yuan J, Li J, Yang X, Li X, Jiang L, Kim ET, Stevenson DA, Viskochil D, Xu M, Yang F-C (2013) Hyperactive Ras\/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice. Hum Mol Genet 22(23):4818\u20134828. https:\/\/doi.org\/10.1093\/hmg\/ddt333","journal-title":"Hum Mol Genet"},{"issue":"5","key":"1094_CR28","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.bone.2005.01.022","volume":"36","author":"X Yu","year":"2005","unstructured":"Yu X, Chen S, Potter OL, Murthy SM, Li J, Pulcini JM, Ohashi N, Winata T, Everett ET, Ingram D, Clapp WD, Hock JM (2005) Neurofibromin and its inactivation of Ras are prerequisites for osteoblast functioning. Bone 36(5):793\u2013802. https:\/\/doi.org\/10.1016\/j.bone.2005.01.022","journal-title":"Bone"},{"issue":"19","key":"1094_CR29","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1093\/hmg\/ddl208","volume":"15","author":"X Wu","year":"2006","unstructured":"Wu X, Estwick SA, Chen S, Yu M, Ming W, Nebesio TD, Li Y, Yuan J, Kapur R, Ingram D, Yoder MC, Yang F-C (2006) Neurofibromin plays a critical role in modulating osteoblast differentiation of mesenchymal stem\/progenitor cells. Hum Mol Genet 15(19):2837\u20132845. https:\/\/doi.org\/10.1093\/hmg\/ddl208","journal-title":"Hum Mol Genet"},{"issue":"4","key":"1094_CR30","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jocd.2019.07.001","volume":"22","author":"CR Shuhart","year":"2019","unstructured":"Shuhart CR, Yeap SS, Anderson PA, Jankowski LG, Lewiecki EM, Morse LR, Rosen HN, Weber DR, Zemel BS, Shepherd JA (2019) Executive summary of the 2019 ISCD position development conference on monitoring treatment, DXA cross-calibration and least significant change, spinal cord injury, peri-prosthetic and orthopedic bone health, transgender medicine, and pediatrics. J Clin Densitometry 22(4):453\u2013471. https:\/\/doi.org\/10.1016\/j.jocd.2019.07.001","journal-title":"J Clin Densitometry"},{"issue":"1","key":"1094_CR31","doi-asserted-by":"publisher","first-page":"e10594","DOI":"10.1002\/jbm4.10594","volume":"6","author":"M Herath","year":"2022","unstructured":"Herath M, Cohen A, Ebeling PR, Milat F (2022) Dilemmas in the management of osteoporosis in younger adults. JBMR Plus 6(1):e10594\u2013e10594. https:\/\/doi.org\/10.1002\/jbm4.10594","journal-title":"JBMR Plus"},{"issue":"4","key":"1094_CR32","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1136\/jmg.2008.061895","volume":"46","author":"T Tucker","year":"2009","unstructured":"Tucker T, Schnabel C, Hartmann M, Friedrich RE, Frieling I, Kruse HP, Mautner VF, Friedman JM (2009) Bone health and fracture rate in individuals with neurofibromatosis 1 (NF1). J Med Genet 46(4):259. https:\/\/doi.org\/10.1136\/jmg.2008.061895","journal-title":"J Med Genet"},{"issue":"5","key":"1094_CR33","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/ajmg.a.35541","volume":"161","author":"JK George-Abraham","year":"2013","unstructured":"George-Abraham JK, Martin LJ, Kalkwarf HJ, Rieley MB, Stevenson DA, Viskochil DH, Hopkin RJ, Stevens AM, Hanson H, Schorry EK (2013) Fractures in children with neurofibromatosis type 1 from two NF clinics. Am J Med Genet A 161(5):921\u2013926. https:\/\/doi.org\/10.1002\/ajmg.a.35541","journal-title":"Am J Med Genet A"},{"issue":"15","key":"1094_CR34","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/hmg\/ddp212","volume":"18","author":"A Sabbagh","year":"2009","unstructured":"Sabbagh A, Pasmant E, Laurendeau I, Parfait B, Barbarot S, Guillot B, Combemale P, Ferkal S, Vidaud M, Aubourg P, Vidaud D, Wolkenstein P et al (2009) Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1. Hum Mol Genet 18(15):2768\u20132778. https:\/\/doi.org\/10.1093\/hmg\/ddp212","journal-title":"Hum Mol Genet"},{"issue":"12","key":"1094_CR35","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1177\/1759720X17732562","volume":"9","author":"WF Lems","year":"2017","unstructured":"Lems WF, Raterman HG (2017) Critical issues and current challenges in osteoporosis and fracture prevention: an overview of unmet needs. Ther Adv Musculoskelet Dis 9(12):299\u2013316. https:\/\/doi.org\/10.1177\/1759720X17732562","journal-title":"Ther Adv Musculoskelet Dis"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-023-01094-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-023-01094-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-023-01094-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T18:19:16Z","timestamp":1690395556000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-023-01094-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,23]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["1094"],"URL":"https:\/\/doi.org\/10.1007\/s00223-023-01094-z","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,23]]},"assertion":[{"value":"10 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Nipith Charoenngam, Phuuwadith Wattanachayakul, Aunchalee Jaroenlarpnopparat, Patompong Ungprasert and Jirat Chenbhanich declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}